Simon G. Williams

发表

Predicting hospitalisation for heart failure and death in patients with, or at risk of, heart failure before first hospitalisation: a retrospective model development and external validation study

E. Schelbert, Christopher A. Miller, M. Schmitt, 2022, The Lancet. Digital health.

Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction

E. Schelbert, Christopher A. Miller, S. Dodd, 2022, Journal of Cardiovascular Translational Research.

Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction

E. Schelbert, Christopher A. Miller, A. Rosala-Hallas, 2022, The International Journal of Cardiovascular Imaging.

Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone

E. Schelbert, Christopher A. Miller, A. Rosala-Hallas, 2022, Journal of the American Heart Association.

Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial

P. Williamson, E. Schelbert, Christopher A. Miller, 2021, Nature Medicine.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.

R. Prescott, D. Eckberg, A. Shah, 2002, Journal of the American College of Cardiology.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Remote management of heart failure using implantable electronic devices

J. Morgan, M. Cowie, P. Roderick, 2017, European heart journal.

Rationale and study design of the REM‐HF study: remote management of heart failure using implanted devices and formalized follow‐up procedures

B. Dimitrov, J. Morgan, M. Cowie, 2014, European journal of heart failure.

Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM‐HF trial

J. Morgan, M. Cowie, J. Gill, 2020, European journal of heart failure.

Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction

E. Schelbert, Christopher A. Miller, A. Rosala-Hallas, 2022, The International Journal of Cardiovascular Imaging.

Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.

J. Morgan, M. Cowie, J. Gill, 2020, International journal of cardiology.

Treatment adherence in a randomised controlled trial of pirfenidone in HFpEF: determinants and impact on efficacy.

E. Schelbert, Christopher A. Miller, A. Rosala-Hallas, 2023, Journal of cardiac failure.